傳水滴公司獲逾2億美元D輪融資
據內地傳媒報道,水滴公司獲逾2億美元D輪融資,由瑞士再保險領投,騰訊(00700.HK)、IDG等跟投。
水滴公司於去年3月獲5億元人民幣B輪融資,並於6月獲10億元人民幣C輪融資。
水滴公司創立於2016年4月,是中國互聯網健康保險保障第一平台,水滴保險商城與水滴互助組成了水滴公司的商業板塊,水滴籌與水滴公益組成了水滴公司的社會責任板塊,兩大板塊共同構成了完善的「事前保障+事後救助」的保險保障體系。
除騰訊和IDG外,水滴公司的投資者還包括美團(03690.HK)、亮點基金、Banyan Capital和真格基金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.